Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 517

2.

Positive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/PDGFRA mutations.

Cao D, Antonescu C, Wong G, Winter J, Maitra A, Adsay NV, Klimstra DS, Hruban RH.

Mod Pathol. 2006 Sep;19(9):1157-63. Epub 2006 Jun 16.

3.

Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma.

Swick BL, Srikantha R, Messingham KN.

J Cutan Pathol. 2013 Jul;40(7):623-30. doi: 10.1111/cup.12160. Epub 2013 Apr 29.

PMID:
23621836
5.

Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.

Tamborini E, Miselli F, Negri T, Lagonigro MS, Staurengo S, Dagrada GP, Stacchiotti S, Pastore E, Gronchi A, Perrone F, Carbone A, Pierotti MA, Casali PG, Pilotti S.

Clin Cancer Res. 2006 Dec 1;12(23):6920-8.

6.

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.

Sihto H, Sarlomo-Rikala M, Tynninen O, Tanner M, Andersson LC, Franssila K, Nupponen NN, Joensuu H.

J Clin Oncol. 2005 Jan 1;23(1):49-57. Epub 2004 Nov 15.

PMID:
15545668
7.

Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate.

Swick BL, Ravdel L, Fitzpatrick JE, Robinson WA.

J Cutan Pathol. 2008 Feb;35(2):197-202. doi: 10.1111/j.1600-0560.2007.00793.x.

PMID:
18190445
8.

Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma.

Waltari M, Sihto H, Kukko H, Koljonen V, Sankila R, Böhling T, Joensuu H.

Int J Cancer. 2011 Aug 1;129(3):619-28. doi: 10.1002/ijc.25720. Epub 2011 Jan 18.

9.

Activating mutations in c-KIT and PDGFRalpha are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes.

Burger H, den Bakker MA, Kros JM, van Tol H, de Bruin AM, Oosterhuis W, van den Ingh HF, van der Harst E, de Schipper HP, Wiemer EA, Nooter K.

Cancer Biol Ther. 2005 Nov;4(11):1270-4. Epub 2005 Nov 18.

PMID:
16294026
10.

Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumours.

Sihto H, Franssila K, Tanner M, Vasama-Nolvi C, Sarlomo-Rikala M, Nupponen NN, Joensuu H, Isola J.

Scand J Gastroenterol. 2006 Jul;41(7):805-11.

PMID:
16785193
11.

Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.

Do I, Araujo ES, Kalil RK, Bacchini P, Bertoni F, Unni KK, Park YK.

Pathol Res Pract. 2007;203(3):127-34. Epub 2007 Feb 12.

PMID:
17298867
12.

Expression of platelet-derived growth factor-alpha receptor and c-kit in giant cell tumours of bone.

Sulzbacher I, Dominkus M, Pichlhofer B, Mazal PR.

Pathology. 2009;41(7):630-3. doi: 10.3109/00313020903257749.

PMID:
20001342
13.

Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity.

Holtkamp N, Okuducu AF, Mucha J, Afanasieva A, Hartmann C, Atallah I, Estevez-Schwarz L, Mawrin C, Friedrich RE, Mautner VF, von Deimling A.

Carcinogenesis. 2006 Mar;27(3):664-71. Epub 2005 Dec 15.

PMID:
16357008
14.

Co-expression of KIT receptor and its ligand stem cell factor in Merkel cell carcinoma.

Krasagakis K, Kruger-Krasagakis S, Eberle J, Tsatsakis A, Tosca AD, Stathopoulos EN.

Dermatology. 2009;218(1):37-43. doi: 10.1159/000173704. Epub 2008 Nov 12.

PMID:
19001805
15.

Oncogenic and ligand-dependent activation of KIT/PDGFRA in surgical samples of imatinib-treated gastrointestinal stromal tumours (GISTs).

Negri T, Bozzi F, Conca E, Brich S, Gronchi A, Bertulli R, Fumagalli E, Pierotti MA, Tamborini E, Pilotti S.

J Pathol. 2009 Jan;217(1):103-12. doi: 10.1002/path.2450.

PMID:
18973210
16.
17.

KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of merkel cell carcinoma in vitro.

Krasagakis K, Fragiadaki I, Metaxari M, Krüger-Krasagakis S, Tzanakakis GN, Stathopoulos EN, Eberle J, Tavernarakis N, Tosca AD.

J Cell Physiol. 2011 Apr;226(4):1099-109. doi: 10.1002/jcp.22431.

PMID:
20857409
18.

The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.

Penzel R, Aulmann S, Moock M, Schwarzbach M, Rieker RJ, Mechtersheimer G.

J Clin Pathol. 2005 Jun;58(6):634-9.

19.

Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series.

Gomes AL, Gouveia A, Capelinha AF, de la Cruz D, Silva P, Reis RM, Pimenta A, Lopes JM.

J Clin Pathol. 2008 Feb;61(2):203-8. Epub 2007 Sep 7.

20.

Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors.

Kang HJ, Nam SW, Kim H, Rhee H, Kim NG, Kim H, Hyung WJ, Noh SH, Kim JH, Yun CO, Liu ET, Kim H.

Oncogene. 2005 Feb 3;24(6):1066-74.

PMID:
15690055

Supplemental Content

Support Center